Abu Jaber, A.M.R.; Basgut, B.; Hawan, A.A.; Al Shehri, A.A.; AlKahtani, S.A.; Ahmed, N.J.; Abdi, A.
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes. Antibiotics 2024, 13, 265.
https://doi.org/10.3390/antibiotics13030265
AMA Style
Abu Jaber AMR, Basgut B, Hawan AA, Al Shehri AA, AlKahtani SA, Ahmed NJ, Abdi A.
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes. Antibiotics. 2024; 13(3):265.
https://doi.org/10.3390/antibiotics13030265
Chicago/Turabian Style
Abu Jaber, Al Maamon R., Bilgen Basgut, Ali Abdullah Hawan, Ali Amer Al Shehri, Sultan Ahmad AlKahtani, Nehad J. Ahmed, and Abdikarim Abdi.
2024. "The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes" Antibiotics 13, no. 3: 265.
https://doi.org/10.3390/antibiotics13030265
APA Style
Abu Jaber, A. M. R., Basgut, B., Hawan, A. A., Al Shehri, A. A., AlKahtani, S. A., Ahmed, N. J., & Abdi, A.
(2024). The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes. Antibiotics, 13(3), 265.
https://doi.org/10.3390/antibiotics13030265